Global Atropine Sulfate Injection Market Report and Forecast 2032

Romy Johsones17 Jun, 2025Business

The Global Atropine Sulfate Injection Market is anticipated to register a CAGR of around 1.8% during the forecast period, i.e., 2025-32. Along with this, the market is valued at USD 756.5 million in 2024. The tropane alkaloid compound atropine sulfate is generally utilized in ophthalmology to dilate pupils during eye examination, treat bradycardia (slow heart rate), and treat organophosphate poisoning. It is an essential component of healthcare settings owing to its application in both routine medical procedures & emergency therapy. The need for atropine sulfate is predicted to upscale in several parts of the world as the prevalence of cardiovascular issues & eye-related ailments elevates. Growing healthcare infrastructure in evolving countries, technological development in medication administration, and advancements in medical research are the major drivers fueling the Atropine Sulfate Market.